Earnings Forecast Research on Geron Corporation (GERN)

Geron Corporation has received $-0.06 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 3 Financial Advisor in the Stock Trading Firms. Among 3 Analysts, Bottom line EPS Estimate for the current quarter is $-0.07 while the top line estimate is $-0.05 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at -13.33%.

Geron Corporation reported better than expected with a surprise EPS of 66.67% or $0.04 during its most recent quarterly earnings. The Actual EPS was $-0.02 compared to the Estimated EPS of $-0.06.

In the last quarter, Geron Corporation reported Annual Earnings of $-0.02. Based on the filings, last years Annual Earnings was, $0. In the last Quarter, GERN reported a surprise Earnings per Share of 66.67% . The consensus estimate for current quarter is $-0.06 and for the current fiscal year, the estimate is $-0.19. For the Next fiscal year, the estimate is $-0.11 based on the consensus.

Geron Corporation (NASDAQ:GERN) : On Tuesday heightened volatility was witnessed in Geron Corporation (NASDAQ:GERN) which led to swings in the share price. The stock opened for trading at $1.91 and hit $2.08 on the upside , eventually ending the session at $2.08, with a gain of 7.77% or 0.15 points. The heightened volatility saw the trading volume jump to 2,064,175 shares. The 52-week high of the share price is $3.35 and the company has a market cap of $331 million. The 52-week low of the share price is at $1.81 .

Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.

Geron

Share this post

Leave a Reply